NASDAQ: PPCB
Propanc Biopharma Inc Stock Ownership - Who owns Propanc Biopharma?

Insider buying vs selling

Have Propanc Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PPCB insiders and whales buy or sell their stock.

PPCB Shareholders

What type of owners hold Propanc Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ubs Group Ag8.02%182,614$262.96kInstitution
Jane Street Group LLC6.29%143,212$206.23kInstitution
Marex Group PLC2.97%67,724$97.52kInstitution
Virtu Financial LLC1.79%40,748$58.68kInstitution
Sassicaia Capital Advisers LLC0.70%16,000$23.04kInstitution
Xtx Topco Ltd0.53%12,098$17.42kInstitution

1 of 1

PPCB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PPCB20.30%0.00%
MTNB1.16%98.84%
AIM1.21%69.87%Net Buying
GOVX0.13%99.87%Net Buying
ENSC3.31%28.92%

Propanc Biopharma Stock Ownership FAQ

Who owns Propanc Biopharma?

Propanc Biopharma (NASDAQ: PPCB) is owned by 20.30% institutional shareholders, 0.00% Propanc Biopharma insiders, and 79.70% retail investors. Ubs Group Ag is the largest individual Propanc Biopharma shareholder, owning 182,614.00 shares representing 8.02% of the company. Ubs Group Ag's Propanc Biopharma shares are currently valued at $323.23k.

If you're new to stock investing, here's how to buy Propanc Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.